Clinical Trial Update: Long-term Safety of Danicopan: IPIG Registry-based Cohort Study

View source ↗

Summary

Clinical trial update on the long-term safety of danicopan in a registry-based cohort for paroxysmal nocturnal hemoglobinuria, currently active but not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• Danicopan (danicopan)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Paroxysmal Nocturnal Hemoglobinuria, PNH | Status: ACTIVE_NOT_RECRUITING